Literature DB >> 6313835

Adrenergic regulation of adipocyte metabolism.

J N Fain, J A Garcĩa-Sáinz.   

Abstract

Adipocytes can be readily isolated from intact adipose tissue. In adipocytes from hamster and human white adipose tissue it is possible to demonstrate beta, alpha 1, and alpha 2 adrenoceptors. Alpha 2 adrenoceptor activation inhibits while beta adrenoceptor activation stimulates cyclic AMP accumulation and lipolysis. The effects of catecholamines on cyclic AMP accumulation are mediated through regulation of adenylate cyclase activity, which is activated through beta adrenoceptors and inhibited through alpha 2 adrenoceptors. Activation of alpha 1 adrenergic receptors has been shown to be associated with elevations of cytosol calcium and increased turnover of phosphatidylinositol. In white adipocytes, the only known alpha 1 adrenergic effects are inhibition of glycogen synthase and stimulation of glycogen phosphorylase via mechanisms distinct from those by which cyclic AMP produces similar end effects. In brown adipocytes, alpha 1 adrenoceptor activation stimulates respiration. Thyroid hormones primarily regulate the sensitivity of adipocytes to beta-adrenergic amines while having little effect on alpha adrenoceptor sensitivity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6313835

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  33 in total

1.  Optic atrophy 1 is an A-kinase anchoring protein on lipid droplets that mediates adrenergic control of lipolysis.

Authors:  Guillaume Pidoux; Oliwia Witczak; Elisabeth Jarnæss; Linda Myrvold; Henning Urlaub; Anne Jorunn Stokka; Thomas Küntziger; Kjetil Taskén
Journal:  EMBO J       Date:  2011-10-07       Impact factor: 11.598

2.  In vivo analysis of white adipose tissue in zebrafish.

Authors:  James E N Minchin; John F Rawls
Journal:  Methods Cell Biol       Date:  2011       Impact factor: 1.441

3.  Multiphasic Regulation of Systemic and Peripheral Organ Metabolic Responses to Cardiac Hypertrophy.

Authors:  Chong Wee Liew; Shanshan Xu; Xuerong Wang; Maximilian McCann; Hyerim Whang Kong; Andrew C Carley; Jingbo Pang; Giamila Fantuzzi; J Michael O'Donnell; E Douglas Lewandowski
Journal:  Circ Heart Fail       Date:  2017-04       Impact factor: 8.790

4.  Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein.

Authors:  P Valet; M Berlan; M Beauville; F Crampes; J L Montastruc; M Lafontan
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

5.  Adrenergic regulation of lipolysis in situ at rest and during exercise.

Authors:  P Arner; E Kriegholm; P Engfeldt; J Bolinder
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

Review 6.  Neural innervation of white adipose tissue and the control of lipolysis.

Authors:  Timothy J Bartness; Yang Liu; Yogendra B Shrestha; Vitaly Ryu
Journal:  Front Neuroendocrinol       Date:  2014-04-13       Impact factor: 8.606

7.  [3H]-idazoxan binds with high affinity to two sites on hamster adipocytes: an alpha 2-adrenoceptor and a non-adrenoceptor site.

Authors:  A C MacKinnon; C M Brown; M Spedding; A T Kilpatrick
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

8.  The effects of different plasma insulin concentrations on lipolytic and ketogenic responses to epinephrine in normal and type 1 (insulin-dependent) diabetic humans.

Authors:  A Avogaro; A Valerio; L Gnudi; A Maran; M Miola; E Duner; C Marescotti; E Iori; A Tiengo; R Nosadini
Journal:  Diabetologia       Date:  1992-02       Impact factor: 10.122

9.  Responses of body fat mobilization to isoproterenol or epinephrine challenge in adult cows: influence of energy level, breed, and body fatness.

Authors:  A Ferlay; Y Chilliard
Journal:  J Anim Sci       Date:  2018-02-15       Impact factor: 3.159

10.  Lipolytic catecholamine resistance due to decreased beta 2-adrenoceptor expression in fat cells.

Authors:  F Lönnqvist; H Wahrenberg; L Hellström; S Reynisdottir; P Arner
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.